S3 Ep50: Picking Away at the Oral Side Effects of Cancer Treatment
CURE Talks Cancer5 Marras 2020

S3 Ep50: Picking Away at the Oral Side Effects of Cancer Treatment

Cancer treatments come with the possibility of a plethora of side effects, some of which are deemed more serious than others.

While many patients are informed on countless occasions of what to be on the lookout for both during and after treatment, in certain situations, some side effects might not get as much attention as they should.

“I think if somebody is in a setting where they're fortunate enough to have a dental team at their (treatment center), and that dental team has done a really good job of cross collaboration, then I think it's almost an immediate,” Dr. Samuel Zwetchkenbaum, dental director in the oral health program at the Rhode Island Department of Health, said in an interview with CURE®.

“In my previous life, (when) I was at University of Michigan, we had a dental team and we attended tumor boards. We really tried to have a presence, but it's a little bit harder, especially in a community like Rhode Island, where we don't have the same presence. Then it requires these one on one relationships.”

In this week’s episode of the “CURE Talks Cancer” podcast, Zwetchkenbaum discussed some of the more common oral side effects patients may experience, provided insight into how patients can go about preventing them from occurring, and more.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(297)

S8 Ep2: Mariska Hargitay Talks About Her Father's Myeloma

S8 Ep2: Mariska Hargitay Talks About Her Father's Myeloma

Actor and advocate Mariska Hargitay has partnered with Bristol Myers Squibb to launch "Investigating Myeloma," a disease awareness campaign honoring the 20th anniversary of her father Mickey Hargitay'...

8 Syys 6min

S8 Ep1: Rob Lowe on His Grandmother's Cancer Journey and Why Clinical Trials Matter

S8 Ep1: Rob Lowe on His Grandmother's Cancer Journey and Why Clinical Trials Matter

In our season 8 premiere, actor and longtime breast cancer advocate Rob Lowe joins CURE Talks Cancer to share his grandmother's breast cancer journey, including the clinical trial that helped prolong ...

31 Elo 14min

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Joulu 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Maalis 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Syys 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Maalis 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Maalis 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Helmi 20246min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
utelias-mieli
rss-duodecim-lehti
rss-hereilla
docemilia
rss-radplus
rss-normaalivinouma
rss-poliisin-mieli
rss-vaasan-yliopiston-podcastit
rss-kasvikutsut